Strand, V <br/><br/>
New therapies in development for autoimmune diseases: their rationale for combination treatment.  [electronic resource] 

 -  Springer seminars in immunopathology  2001 
 - 43-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0344-4325 
<br/><br/><label>Standard No.: </label>10.1007/s002810100071  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Animals<br/>Antibodies, Blocking--therapeutic use<br/>Arthritis, Rheumatoid--immunology<br/>Autoimmune Diseases--immunology<br/>B-Lymphocytes--immunology<br/>Combined Modality Therapy<br/>Cytokines--antagonists & inhibitors<br/>Drug Therapy, Combination<br/>Histocompatibility Antigens Class II--immunology<br/>Humans<br/>Lupus Erythematosus, Systemic--immunology<br/>Receptors, Antigen, T-Cell--immunology<br/>T-Lymphocytes--immunology<br/>Treatment Outcome